SR

Srinivasa Reddy Byreddy

Active Director Director DIN 11520839
DIN 11520839 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivasa Reddy Byreddy

Data last updated:

Srinivasa Reddy Byreddy is a Director at Cleocure Lifesciences Private Limited (since 2026). The company operates in Pharma.

DIN 11520839
Primary Designation Director
Industry Pharma
First Appointment 03 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Feb 20262026Active

Board colleagues of Srinivasa Reddy Byreddy

NameDINCompanyDesignation
Mallareddy Veldi11520840Cleocure Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cleocure Lifesciences Private Limited
Premium access

Shareholding and investment profile for Srinivasa Reddy Byreddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Reddy Byreddy

Srinivasa Reddy Byreddy currently holds 1 directorship: Cleocure Lifesciences Private Limited (Director, since 03 Feb 2026).

Srinivasa Reddy Byreddy was first appointed on 03 Feb 2026 as Director at Cleocure Lifesciences Private Limited.

The current boards of Srinivasa Reddy Byreddy's companies include Mallareddy Veldi (Cleocure Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available